Circulating Tumor Cells Predict How Hormone-Resistant Prostate Cancer Patients Fare
Circulating Tumor Cells and Prostate Cancer
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy.
The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, the researchers say.
The team of scientists